Loxoprofen sodium matrix sustained-release tablet

The invention relates to a novel matrix sustained-release tablet containing loxoprofen sodium, in particular to a locoprofen sodium matrix sustained-release tablet with a regulation layer, which is capable of stably releasing for 8 hours, good in releasing effect, simple in process and low in cost.

Saved in:
Bibliographic Details
Main Authors YI WEIFENG, LIANG XI, LIU QUANZHI, DI YUAN, YANG WENBIN, ZHANG QIANG, JIANG QINGWEI, GE ZHENZHONG
Format Patent
LanguageChinese
English
Published 04.07.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to a novel matrix sustained-release tablet containing loxoprofen sodium, in particular to a locoprofen sodium matrix sustained-release tablet with a regulation layer, which is capable of stably releasing for 8 hours, good in releasing effect, simple in process and low in cost.
AbstractList The invention relates to a novel matrix sustained-release tablet containing loxoprofen sodium, in particular to a locoprofen sodium matrix sustained-release tablet with a regulation layer, which is capable of stably releasing for 8 hours, good in releasing effect, simple in process and low in cost.
Author LIU QUANZHI
YI WEIFENG
DI YUAN
LIANG XI
JIANG QINGWEI
YANG WENBIN
GE ZHENZHONG
ZHANG QIANG
Author_xml – fullname: YI WEIFENG
– fullname: LIANG XI
– fullname: LIU QUANZHI
– fullname: DI YUAN
– fullname: YANG WENBIN
– fullname: ZHANG QIANG
– fullname: JIANG QINGWEI
– fullname: GE ZHENZHONG
BookMark eNrjYmDJy89L5WQw9MmvyC8oyk9LzVMozk_JLM1VyE0sKcqsUCguLS5JzMxLTdEtSs1JTSxOVShJTMpJLeFhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoYGRqZGppYWlo7GxKgBANcXLhQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN102525989A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN102525989A3
IEDL.DBID EVB
IngestDate Fri Jul 19 16:20:39 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN102525989A3
Notes Application Number: CN2011100292
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120704&DB=EPODOC&CC=CN&NR=102525989A
ParticipantIDs epo_espacenet_CN102525989A
PublicationCentury 2000
PublicationDate 20120704
PublicationDateYYYYMMDD 2012-07-04
PublicationDate_xml – month: 07
  year: 2012
  text: 20120704
  day: 04
PublicationDecade 2010
PublicationYear 2012
RelatedCompanies BEIJING TIANHENG DRUG RESEARCH INSTITUTE
RelatedCompanies_xml – name: BEIJING TIANHENG DRUG RESEARCH INSTITUTE
Score 2.943933
Snippet The invention relates to a novel matrix sustained-release tablet containing loxoprofen sodium, in particular to a locoprofen sodium matrix sustained-release...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Loxoprofen sodium matrix sustained-release tablet
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120704&DB=EPODOC&locale=&CC=CN&NR=102525989A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU9LM7JIAvZOLEAp2CQlzVjXAjTMkZKWBLr-KCUpEXw3oK-fmUeoiVeEaQQTQxZsLwz4nNBy8OGIwByVDMzvJeDyugAxiOUCXltZrJ-UCRTKt3cLsXVRg_aODY2AKdhEzcXJ1jXA38XfWc3Z2dbZT80vCNjWNTIFtvQtLB2ZGVhBzWjQOfuuYU6gXSkFyFWKmyADWwDQtLwSIQamqgxhBk5n2M1rwgwcvtAJbyATmveKRRgMffIr8kFXbKfmKRTnp2SW5irkgs7Xr1AohmyCSk3RBd2AAqyWFEpAG6JKRBkU3VxDnD10gXbHwz0a7-yHcKaxGANLXn5eqgSDQqqhSapFUoqFaVqquUlSYmKipYk5sJllYGiRbGSZZpIkySCF2xwpfJLSDFygQAMvPzWRYWApKSpNlQVWsiVJcuDQAQCFg4FL
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUYP4NROzN6IbneseFiMdZCobxKDhjaysi5iwETci8a_3WkF80bemTfpx6fWu1_7uB3BpJ4lJOd5OqNzBJE6aDSrDHHHCJf1RzCPFDRiEN_4zeRhawxK8rbAwKk_oh0qOiBo1Rn0v1Hk9WwexPPW3Mr_iE6zKbjsD19OXt2PDxB1MdK_ltvs9r8d0xlwW6uET-rqmhZ4-de42YNOW2Xml6_TSkqiU2W-T0tmFrT72lhZ7UPp8rUKFrZjXqrAdLB-8sbjUvXwfjG62yCTFtki1PIsn86k2lfn1F1r-DYIScUMyoKBZ0goJiCoO4KLTHjC_gWOPfhY6YuF6ms1DKKdZKmqgCYMIymNqJcImPIoih9joZl0bdGw6CeFHUP-7n_p_jedQ8QdBd9S9Dx-PYUcKUH1FJSdQLt7n4hQNbsHPlKS-ALnQhDg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Loxoprofen+sodium+matrix+sustained-release+tablet&rft.inventor=YI+WEIFENG&rft.inventor=LIANG+XI&rft.inventor=LIU+QUANZHI&rft.inventor=DI+YUAN&rft.inventor=YANG+WENBIN&rft.inventor=ZHANG+QIANG&rft.inventor=JIANG+QINGWEI&rft.inventor=GE+ZHENZHONG&rft.date=2012-07-04&rft.externalDBID=A&rft.externalDocID=CN102525989A